Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Financing › Details

Nuritas–SEVERAL: investment, 202111 financing round Series B $45m led by Cleveland Avenue + incl ECBF

 

Period Period 2021-11-11
Organisations Money taker Nuritas Ltd.
  Money source SEVERAL
Products Product peptide library
  Product 2 venture capital
Person Person Asano, Marie (European Circular Bioeconomy Fund 202111 Princiap before HTGF 201902 Investment Manager)
     

ECBF Management GmbH. (11/11/21). "Press Release: European Circular Bioeconomy Fund (ECBF) Invests $7 Million USD in Irish AI-discovery Platform Company Nuritas". Dublin & Luxembourg.

> ECBF joined Nuritas’ $45M financing round alongside lead investor Cleveland Avenue and additional investors including Wheatsheaf Group, Vertex holdings, Veronorte and CJ

> Funding will serve to scale Nuritas´ AI platform Np?™ as well as to accelerate the global expansion of sustainable, healthier, plant-based food and consumer products


The European Circular Bioeconomy Fund (ECBF) has invested approximately $7 million USD in the $45 million USD Series B financing round of Nuritas, a biotechnology company revolutionizing the discovery and use of plant-based bioactive peptides through artificial intelligence (AI) and genomics. The round was led by Chicago-based Cleveland Avenue and additional investors including Grosvenor’s Wheatsheaf Group, Vertex holdings, Veronorte and CJ. Previous rounds were led by Cultivian Sandbox Ventures and Singapore-based VisVires New Protein, both of whom participated in this round. Other early investors include U2’s Bono and The Edge, Salesforce CEO Marc Benioff and Ali Partovi. This brings total funding to date of $75 million USD.

This new funding will accelerate Nuritas’ global expansion and support its mission to unlock the power of nature to make many of the products we consume daily healthier, safer and more sustainable.

“The mission and vision of Nuritas™ are in line with the zeitgeist of our time. There is an ever pressing demand for clean label products that maximize human well-being and health while simultaneously contributing towards a more sustainable, plant-based economy,” said Marie Asano, Principal at ECBF.


ECBF Management GmbH
Poppelsdorfer Allee 17 | 53115 Bonn | Germany
T.: +49 160 892 7744
info@ecbf.vc | www.ecbf.vc

   
Record changed: 2024-01-09

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Nuritas Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top